Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 5, 2003, Pages 686-692

  Emdin, Michele ^a   Passino, Claudio ^a   Del Ry, Silvia ^a   Prontera, Concetta ^a   Galetta, Fabio ^b   Clerico, Aldo ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

ANP; BNP; Cardiac hormones; Gender; Heart failure

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; IMMUNORADIOMETRIC ASSAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; CARDIAC OUTPUT, LOW; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 0037665895     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.104     Document Type: Article

References (39)

1. Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular diseases. Clin Sci 1998; 95:519-29.
2. Clerico A, Iervasi G, Mariani G. Clinical relevance of the measurement of cardiac natriuretic peptide hormones in humans. Horm Metab Res 1999; 31:487-98.
3. Boomsma F, Van den Meiracker AH. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res 2001; 51:442-9.
4. Suzuki T, Yamazaki T, Yazaki Y. The role of the natriuretic peptides in the cardiovascular system. Cardiovasc Res 2001; 51:489-94.
5. Mair J, Hammerer-Lercher A, Puchendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001; 39:571-88.
6. Maisel A. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. J Cardiac Failure 2001; 7:183-93.
7. Struthers AD. Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only. Heart 2002; 87: 97-8.
8. Maron DJ, Ridker PM, Pearson TA, Grundy SM. Dyslipidemia, other risk factors, and the prevention of coronary heart disease. In: Fuster V, Alexander RW, O'Rourke RA, Roberts R, King SB, Wellens HJJ, editors. Hurst's - the heart, 10th ed. New York: McGraw Hill Companies Inc, 2001:1131-60.
9. Kuroski de Bold ML. Estrogen, natriuretic peptides and the renin-angiotensin system. Cardiovasc Res 1999; 41:524-31.
10. Rosano GMC, Chierchia SL, Leonardo F, Beale CM, Collins P. Cardioprotective effects of ovarian hormones. Eur Heart J 1996; 17(Suppl D):15-9.
11. Sotelo MM, Johnson RS. The effects of hormone replacement therapy on coronary heart disease. Endocrinol Metab Clin North Am 1997; 26:313-28.
12. Johnson SR. Menopause and hormone replacement therapy. Med Clin North Am 1998; 82: 297-20.
13. Clinical Synthesis Panel on HRT. Hormone replacement therapy. Lancet 1999; 354:152-5.
14. Lakatta EG, Boluyt MO. Age-associated changes in the cardiovascular system in the absence of cardiovascular disease. In: Hosenpud JD, Greenberg BH, editors. Congestive heart failure, 2nd ed. Philadelphia: Lippincott Willians & Wilkins, 2000:137-56.
15. Clark BA, Elahi D, Epstein FH. The influence of gender, age, and the menstrual cycle on plasma atrial natriuretic peptide. J Clin Endocrinol Metab 1990; 70:349-52.
16. Maffei S, Clerico A, Iervasi G, Nannipieri M, Del Ry S, Giannessi D, et al. Circulating levels of cardiac natriuretic hormones measured in women during menstrual cycle. J Endocrinol Invest 1999; 22:1-5.
17. Clerico A, Iervasi G, Del Chicca MG, Emdin M, Maffei S, Nannipieri M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 1998; 21:170-9.
18. Jensen KT, Carstens J, Ivarsen P, Pedersen EB. A new, fast, and reliable radioimmunoassay of brain natriuretic peptide in human plasma; reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997; 57:529-40.
19. Del Ry S, Clerico A, Giannessi D, Andreassi MG, Caprioli R, Iascone MR, et al. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an IRMA method. Scand J Clin Lab Invest 2000; 60:81-90.
20. Naruse M, Takeyama Y, Tanabe A, Hiroshige J, Naruse K, Yoshimoto T, et al. Atrial and brain natriuretic peptides in cardiovascular diseases. Hypertension 1994; 23 (Suppl 1):I231-4.
21. Yoshibayashi M, Saito Y, Nakao K. Brain natriuretic peptide versus atrial natriuretic peptide - physiological and pathophysiological significance in children and adults: a review. Eur J Endocrinol 1996; 135:265-8.
22. Clerico A, Del Ry S, Maffei S, Prontera C, Emdin M, Giannessi D. Circulating levels of cardiac natriuretic hormones in healthy adult subjects: Effects of aging and sex. Clin Chem Lab Med 2002; 40:371-7.
23. Luchner A, Brockel U, Muscholl M, Hense HW, Doring A, Riegger GAJ, et al. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res 2002; 53:720-7.
24. Josephson RA, Fannin S, Rinaldi J. Physiology of the aging heart. In: Chesler E, editor. Clinical cardiology in the elderly, 2nd ed. Armonk (N.Y.): Futura Publishing Company, Inc., 1999:51-77.
25. Clerico A, Del Ry S, Giannessi D. Measurement of natriuretic cardiac hormones (ANP, BNP, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin Chem 2000; 46:1529-34.
26. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350:1349-53.
27. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congetsive heart failure in the United States. J Am Coll Cardiol 1992; 20:301-6.
28. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22(SupplA):6a-13a.
29. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, et al. Symptomatic and asymptomatic left-centricular systolic dysfunction in an urban population. Lancet 1997; 350:829-33.
30. Clinical Quality Improvement Network Investigators. Mortality risk and patterns of practisce in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Arch Intern Med 1996; 156:1669-73.
31. Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996; 28:1781-8.
32. Adams KF Jr, Sueta CA, Gheorghiade M, O'Connor CM, Schwartz TA, Koch GG, et al. Gender differences in survival in advanced heart failure. Insight from the FIRST study. Circulation 1999; 99:1816-21.
33. Philbin EF, DiSalvo TG. Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. Am J Cardiol 1998; 82:76-81.
34. Maffei S, Del Ry S, Prontera C, Clerico A. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Clin Sci 2001; 101:447-53.
35. Clerico A, Iervasi G, Del Chicca MG, Maffei S, Berti S, Sabatino L, et al. Analytical performance and clinical usefulness of a commercially available IRMA kit for the measurement of atrial natriuretic peptide in patients with heart failure. Clin Chem 1996; 42:1627-33.
36. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, et al. Gender differences in molecular remodelling in pressure overload hypertrophy. J Am Coll Cardiol 1999; 34:264-73.
37. Tamura T, Said S, Gerdes AM. Gender-related differences in myocyte remodelling in progression to heart failure. Hypertension 1999; 33: 676-80.
38. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002; 90 254-8.
39. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002; 40:976-82.